Adverse cardiovascular drug interactions-Reference-Cited by-同舟云学术

Adverse cardiovascular drug interactions

Published:2000-09 Issue:9 Volume:25 Page:621-676
ISSN:0146-2806
Container-title:Current Problems in Cardiology
language:en
Short-container-title:Current Problems in Cardiology

Author:

Opie Lionel H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Reference176 articles.

1. Molecular basis of cardiovascular drug metabolism: implications for predicting clinically important drug interactions;Abernethy;Circulation,2000

2. Summary statement of the American College of Cardiology and the American Heart Association on the use of sildenafil (Viagra) in patients at clinical risk from cardiovascular effects;ACC-AHA;Clinician Reviews,1998

3. Interaction between fenofibrate and warfarin;Ascah;Ann Pharmacother,1998

4. Safety and efficacy of long-term statin-fibrate combinations in patients with refractory familial combined hyperlipidemia;Athyros;Am J Cardiol,1997

5. Drug action, reaction and interaction: I. quinidine for cardiac arrhythmias;Aviado;J Clin Pharmacol,1975

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Signal Detection in Pharmacovigilance: A Review of Informatics-driven Approaches for the Discovery of Drug-Drug Interaction Signals in Different Data Sources;Artificial Intelligence in the Life Sciences;2021-12

3. Endoplasmic Reticulum Stress Activates Unfolded Protein Response Signaling and Mediates Inflammation, Obesity, and Cardiac Dysfunction: Therapeutic and Molecular Approach;Frontiers in Pharmacology;2019-09-10

4. In-vitro drug–drug interaction studies of diltiazem with floroquinolones;Journal of Liquid Chromatography & Related Technologies;2017-12-05

5. Pharmacointeraction Network Models Predict Unknown Drug-Drug Interactions;PLoS ONE;2013-04-19